or Try an Advanced Search...

    Technical Analysis for EXAI - Exscientia Limited

    Grade Last Price % Change Price Change
    C 5.15 0.98% 0.05
    EXAI closed up 0.98 percent on Monday, July 1, 2024, on 63 percent of normal volume.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical EXAI trend table...
    Date Alert Name Type % Chg
    Doji - Bullish? Reversal 0.00%
    Outside Day Range Expansion 0.00%
    Fell Below 20 DMA Bearish -1.34%
    Doji - Bullish? Reversal -1.34%
    20 DMA Support Bullish -2.83%
    20 DMA Support Bullish -2.65%
    NR7 Range Contraction -2.65%
    Bearish Engulfing Bearish -1.72%
    20 DMA Support Bullish -4.45%
    Pocket Pivot Bullish Swing Setup -4.45%
    Older End-of-Day Signals for EXAI ...

       Recent Intraday Alerts

    Alert Time
    Outside Day about 7 hours ago
    Fell Below Previous Day's Low about 7 hours ago
    Down 1% about 7 hours ago
    60 Minute Opening Range Breakdown about 9 hours ago
    Rose Above 10 DMA about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    EXAI Chart by TradingView
    Basic chart:

    Profile

    Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our pipeline demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 25 projects advancing, including the first three AI-designed drug candidates to enter Phase 1 clinical trials.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Artificial Intelligence Health Sciences Clinical Trial Precision Medicine Clinical Pharmacology Systems Biology Evidence Based Medicine

    Is EXAI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 19 How Much Upside is Left in Exscientia (EXAI)? Wall Street Analysts Think 61.43%
    Jun 10 Exscientia: Too Much Pessimism
    Jun 6 Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in Oncology
    Jun 3 Can Exscientia (EXAI) Climb 57.17% to Reach the Level Wall Street Analysts Expect?
    May 30 Exscientia to Present at Upcoming Investor Conferences in June
    May 25 Analysts Are Upgrading Exscientia plc (NASDAQ:EXAI) After Its Latest Results
    May 24 Exscientia plc (EXAI) Q1 2024 Earnings Call Transcript
    May 23 The 3 Best Machine Learning Stocks to Quadruple Your Money by 2035
    May 23 Exscientia (EXAI) Upgraded to Buy: Here's What You Should Know
    May 22 Regeneron faces new biosimilar threats; An AI biotech lays off staff
    See more EXAI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.12
    52 Week Low 3.86
    Average Volume 510,039
    200-Day Moving Average 5.55
    50-Day Moving Average 4.98
    20-Day Moving Average 5.30
    10-Day Moving Average 5.23
    Average True Range 0.31
    RSI (14) 49.49
    ADX 10.21
    +DI 19.36
    -DI 17.91
    Chandelier Exit (Long, 3 ATRs) 5.15
    Chandelier Exit (Short, 3 ATRs) 5.54
    Upper Bollinger Bands 5.89
    Lower Bollinger Band 4.71
    Percent B (%b) 0.37
    BandWidth 22.22
    MACD Line 0.03
    MACD Signal Line 0.05
    MACD Histogram -0.0218
    Fundamentals Value
    Market Cap 643.44 Million
    Num Shares 125 Million
    EPS -1.48
    Price-to-Earnings (P/E) Ratio -3.48
    Price-to-Sales 34.58
    Price-to-Book 1.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.57
    Resistance 3 (R3) 5.57 5.43 5.50
    Resistance 2 (R2) 5.43 5.32 5.43 5.48
    Resistance 1 (R1) 5.29 5.26 5.29 5.29 5.45
    Pivot Point 5.15 5.15 5.15 5.15 5.15
    Support 1 (S1) 5.01 5.04 5.01 5.01 4.85
    Support 2 (S2) 4.87 4.98 4.87 4.82
    Support 3 (S3) 4.73 4.87 4.80
    Support 4 (S4) 4.73